Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

Linda J. C. van Waalwijk van Doorn, Juan D. Gispert, H. Bea Kuiperij, Jurgen A. H. R. Claassen, Andrea Arighi, Ines Baldeiras, Kaj Blennow, Marco Bozzali, Miguel Castelo-Branco, Enrica Cavedo, Derya D. Emek-Savas, Erden Eren, Paolo Eusebi, Lucia Farotti, Chiara Fenoglio, Juan Fortea Ormaechea, Yvonne Freund-Levi, Giovanni B. Frisoni, Daniela Galimberti, Sermin GencViviana Greco, Harald Hampel, Sanna-Kaisa Herukka, Yawu Liu, Albert Llado, Alberto Lleo, Flavio M. Nobili, Kader K. Oguz, Lucilla Parnetti, Joao Pereira, Agnese Picco, Maria Pikkarainen, Catarina Resende de Oliveira, Esen Saka, Nicola Salvadori, Raquel Sanchez-Valle, Isabel Santana, Elio Scarpini, Philip Scheltens, Hilkka Soininen, Roberto Tarducci, Charlotte Teunissen, Magda Tsolaki, Andrea Urbani, Eduard Vilaplana, Pieter Jelle Visser, Asa K. Wallin, Gorsev Yener, Jose L. Molinuevo, Olga Meulenbroek, Marcel M. Verbeek*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)543-555
Number of pages13
JournalJournal of Alzheimer's Disease
Volume56
Issue number2
DOIs
Publication statusPublished - 2017

Keywords

  • Alzheimer's disease
  • amyloid biomarkers
  • cerebrospinal fluid
  • lateral ventricles
  • tau protein
  • MILD COGNITIVE IMPAIRMENT
  • AD-CSF-INDEX
  • NATIONAL INSTITUTE
  • ASSOCIATION WORKGROUPS
  • DIAGNOSTIC GUIDELINES
  • BRAIN ATROPHY
  • BIOMARKERS
  • DEMENTIA
  • RECOMMENDATIONS
  • TAU

Cite this